[Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
D000293:Adolescent; D002648:Child; D004359:Drug Therapy, Combination; D010450:Endopeptidases / Q000008:administration & dosage*; D005260:Female; D005921:Glomerulonephritis / Q000097:blood / Q000188:drug therapy*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*; D000979:alpha-2-Antiplasmin / Q000032:analysis*
D000979:alpha-2-Antiplasmin; D006493:Heparin; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator